Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine

Autor: Hilberink, Jacobien R, van Zeventer, Isabelle A, Chitu, Dana A, Pabst, Thomas, Klein, Saskia K, Stussi, Georg, Griskevicius, Laimonas, Valk, Peter J M, Cloos, Jacqueline, van de Loosdrecht, Arjan A, Breems, Dimitri, van Lammeren-Venema, Danielle, Boersma, Rinske, Jongen-Lavrencic, Mojca, Fehr, Martin, Hoogendoorn, Mels, Manz, Markus G, Söhne, Maaike, van Marwijk Kooy, Rien, Deeren, Dries, van der Poel, Marjolein W M, Legdeur, Marie Cecile, Tick, Lidwine, Chalandon, Yves, Ammatuna, Emanuele, Blum, Sabine, Löwenberg, Bob, Ossenkoppele, Gert J, Huls, Gerwin

Publikováno v: Hilberink, Jacobien R; van Zeventer, Isabelle A; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; ... (2023). Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal, 13(1), p. 93. Springer Nature 10.1038/s41408-023-00850-6

Treatment choice according to the individual conditions remains challenging, particularly in older patients with acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS). The impact of performance status, comorbidities, and physical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5452e6b03128eddc4ddbf85de6c22c25
https://boris.unibe.ch/183546/1/s41408-023-00850-6.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts

Autor: Douma, Renée A, le Gal, Grégoire, Söhne, Maaike, Righini, Marc, Kamphuisen, Pieter W, Perrier, Arnaud, Kruip, Marieke J H A, Bounameaux, Henri, Büller, Harry R, Roy, Pierre-Marie

Publikováno v: BMJ: British Medical Journal, 2010 May 01. 340(7753), 962-962.

Externí odkaz: https://www.jstor.org/stable/40701962

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Quality of clinical Direct Oral Anticoagulants (DOACs) prescribing and identification of risk factors for inappropriate prescriptions

Autor: Zhang, Zhu Xian, van de Garde, Ewoudt Meine Walraven, Söhne, Maaike, Harmsze, Ankie Maxelante, van den Broek, Marcel Pieter Henricus

AIMS: Even though the use of Direct Oral Anticoagulants (DOACs) is safe based on clinical outcomes, drug safety also depends on appropriateness of drug prescription, which is challenging for DOACs since many patient factors need to be considered. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______101::b460d206a4fe150dafa49f9766357717
https://dspace.library.uu.nl/handle/1874/428415